| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 231 |
| 1 | ADALIMUMAB-AATY | 202 |
| 2 | ADALIMUMAB-ADAZ | 195 |
| 3 | ADALIMUMAB-FKJP | 191 |
| 4 | INFLIXIMAB | 138 |
| 5 | METHOTREXATE SODIUM | 58 |
| 6 | METHOTREXATE | 51 |
| 7 | ETANERCEPT | 26 |
| 8 | AZATHIOPRINE | 20 |
| 9 | FOLIC ACID | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-FKJP | 191 | 0.0042 |
| 1 | ADALIMUMAB-AATY | 202 | 0.0041 |
| 2 | ADALIMUMAB-ADAZ | 195 | 0.0035 |
| 3 | DEFLAZACORT | 5 | 0.0019 |
| 4 | CALCIFEDIOL | 3 | 0.0012 |
| 5 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 6 | BETAMETHASONE VALERATE FOAM | 3 | 0.0007 |
| 7 | INFLIXIMAB | 138 | 0.0006 |
| 8 | ACITRETIN | 3 | 0.0006 |
| 9 | BIMEKIZUMAB | 13 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 344 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 51 |
| 2 | Interleukin-17A Antagonist [EPC] | 40 |
| 3 | Corticosteroid [EPC] | 34 |
| 4 | Interleukin-23 Antagonist [EPC] | 23 |
| 5 | Purine Antimetabolite [EPC] | 20 |
| 6 | Vitamin B12 [EPC] | 20 |
| 7 | Aminosalicylate [EPC] | 19 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 9 | Vitamin C [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 40 | 0.0011 |
| 1 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 344 | 0.0003 |
| 4 | Interleukin-23 Antagonist [EPC] | 23 | 0.0002 |
| 5 | Purine Antimetabolite [EPC] | 20 | 0.0002 |
| 6 | Aminosalicylate [EPC] | 19 | 0.0002 |
| 7 | Interleukin-12 Antagonist [EPC] | 16 | 0.0002 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 51 | 0.0001 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 11 | 0.0001 |